The Patent Finder

Paloma Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Paloma Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Paloma Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US RE46,558Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
Formerly held
Lapsed on the fee record
Ended Jul 2, 2025 · USPTO record
Lapsed on the fee recordEnded Jul 2, 2025USPTO record
US 9,381,187Radiation countermeasure agents
Formerly held
Lapsed on the fee record
Ended Jul 5, 2024 · USPTO record
Lapsed on the fee recordEnded Jul 5, 2024USPTO record
US 6,599,921Non-steroidal estrogen receptor ligands
Term ended
Term ended Aug 21, 2021 · USPTO record
Term endedTerm ended Aug 21, 2021USPTO record
US 8,475,776Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
Formerly held
Surrendered on reissue
Surrendered on reissue Sep 26, 2017 · USPTO record
Surrendered on reissueSurrendered on reissue Sep 26, 2017USPTO record
US 6,632,835Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
Lapsed on the fee record
Ended Oct 14, 2015 · USPTO record
Lapsed on the fee recordEnded Oct 14, 2015USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited